Transformative Policy Innovations for Mitigating HIV Drug Resistance: Integrating Genomic Insights and Global Health Strategies
Keywords:
HIV Drug Resistance, Genomic Surveillance, Global Health Policy, Molecular Epidemiology.Abstract
HIV drug resistance is a major obstacle in the global fight against the HIV/AIDS epidemic. The rise of resistant viral strains threatens the effectiveness of antiretroviral therapy (ART). This situation increases treatment costs and negatively affects patient outcomes. This paper looks at new policy ideas to reduce HIV drug resistance by combining genomic insights with global health strategies.
Improvements in genomic tracking and molecular epidemiology have made it possible to detect resistance-related mutations early. This offers valuable chances for personalized treatment plans and evidence-based public health actions. The study discusses how genomic data can shape treatment guidelines, improve surveillance systems, and aid focused prevention efforts.
It also stresses the need for international cooperation, fair access to diagnostic tools, ongoing healthcare funding, and skill development in low-resource areas. By connecting scientific advancements with policy change, this paper suggests a clear plan for lowering HIV drug resistance and enhancing long-term treatment results. The findings show that merging genomic technologies with national and global HIV initiatives is crucial for controlling the epidemic sustainably and meeting global health targets.
References
1. Doyle, T., Smith, C., & Vitoria, M. (2020). Scientific advances in resistance testing and reservoir research for combating HIV drug resistance. Journal of Antiviral Therapy, 25(3), 145–152.
2. Gostin, L. O., Monahan, J. T., & Kaldor, J. (2020). Legal frameworks for equity and inclusion in global health. Health and Human Rights Journal, 22(2), 45–60.
3. Kassaye, S., Ayalew, M., & Gebreyesus, H. (2021). Community-led health initiatives and their role in improving antiretroviral adherence. African Journal of Public Health, 19(4), 203–214.
4. Li, X., Zhan, Q., & Wang, H. (2023). Broadly neutralizing antibodies and long-acting therapies: Innovations in HIV treatment. Current HIV Research, 21(1), 33–46.
5. UNAIDS. (2023). Addressing social inequalities in HIV care: Best practices and strategies. UNAIDS Global Report, 2023 Edition, Geneva: UNAIDS.
6. World Health Organization (WHO). (2023). Strengthening global health systems to combat HIV resistance. WHO Technical Report Series, 2023.
7. Global Fund. (2022). Collaborative initiatives to fight AIDS, tuberculosis, and malaria: A global perspective. Global Fund Progress Report, 2022.
8. UNAIDS. (2023). Integrated health systems: Lessons from Rwanda and Botswana. UNAIDS Case Study Report, Geneva: UNAIDS.
